Euglycemic ketoacidosis is an acute, life-threatening emergency that is characterized by euglycemia, metabolic acidosis, and ketonemia. It is a well-recognized adverse event in diabetic patients taking sodium-glucose cotransporter-2 inhibitor (SGLT-2 inhibitor). However, there is limited data on SGLT-2 inhibitor-related euglycemic ketoacidosis in non-diabetic patients.
View Article and Find Full Text PDFJCEM Case Rep
September 2024
Euglycemic ketoacidosis is a medical emergency characterized by euglycemia, metabolic acidosis, and ketonemia. It is a well-recognized adverse event in patients with diabetes taking sodium-glucose cotransporter-2 inhibitors. However, little has been reported about euglycemic ketoacidosis using glucagon-like peptide-1 (GLP-1) receptor agonists like semaglutide.
View Article and Find Full Text PDFBackground: Recent regulatory changes have limited the access to a widely used commercially available bioengineered acellular dermal matrix (BADM) product as a spacer graft in the surgical correction of lower eyelid retraction. We report our off-label usage of Mucograft, a porcine BADM, as an alternative BADM.
Methods: A retrospective review was conducted of patients undergoing bilateral lower lid surgery with Mucograft (12 eyes) at a single institution.
The present study focused on the temporal variability, meteorological influences, potential sources, and long-range transport of atmospheric aerosols over two contrasting environments during 2011-2013. We have chosen Agartala (AGR) city in Northeast India as one of our sites representing the rural-continental environment and Patiala (PTA) as an urban site in Northwest India. The seasonal averaged equivalent black carbon (eBC) concentration in AGR ranges from 1.
View Article and Find Full Text PDFPurpose: To describe the demography, clinical settings and outcomes in 2071 patients undergoing evisceration across a multi-tier ophthalmology hospital network and comparison of results with the global scenario of clinical settings for evisceration.
Methods: An analysis of 2071 patients undergoing evisceration and implant between 2013 and 2019.
Results: The mean age at surgery was 39 ± 22 years.